494 related articles for article (PubMed ID: 31429616)
1. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing
Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N
Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616
[No Abstract] [Full Text] [Related]
2. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
[TBL] [Abstract][Full Text] [Related]
3. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
4. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA
Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838
[TBL] [Abstract][Full Text] [Related]
5. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study.
Collingwood JD; Wang L; Aban IB; Yarbrough AH; Boppana SB; Dangle PP
J Pediatr Urol; 2023 Feb; 19(1):129.e1-129.e7. PubMed ID: 36344365
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
[TBL] [Abstract][Full Text] [Related]
9. Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study.
Castillo-Tokumori F; Irey-Salgado C; Málaga G
Int J Infect Dis; 2017 Feb; 55():16-19. PubMed ID: 27979787
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department.
Lee H; Han SB; Kim JH; Kang S; Durey A
Am J Emerg Med; 2018 Sep; 36(9):1608-1612. PubMed ID: 29373168
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants.
Hernández Marco R; Guillén Olmos E; Bretón-Martínez JR; Giner Pérez L; Casado Sánchez B; Fujkova J; Salamanca Campos M; Nogueira Coito JM
Enferm Infecc Microbiol Clin; 2017 May; 35(5):287-292. PubMed ID: 26976379
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
Roldan-Masedo E; Sainz T; Gutierrez-Arroyo A; Gomez-Gil RM; Ballesteros E; Escosa L; Baquero-Artigao F; Méndez-Echevarría A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2097-2102. PubMed ID: 31359255
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA
PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052
[TBL] [Abstract][Full Text] [Related]
14. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
Søraas A; Sundsfjord A; Jørgensen SB; Liestøl K; Jenum PA
PLoS One; 2014; 9(1):e85889. PubMed ID: 24454943
[TBL] [Abstract][Full Text] [Related]
15. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
[TBL] [Abstract][Full Text] [Related]
16. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children.
Kizilca O; Siraneci R; Yilmaz A; Hatipoglu N; Ozturk E; Kiyak A; Ozkok D
Pediatr Int; 2012 Dec; 54(6):858-62. PubMed ID: 22882781
[TBL] [Abstract][Full Text] [Related]
18. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015.
Chervet D; Lortholary O; Zahar JR; Dufougeray A; Pilmis B; Partouche H
Med Mal Infect; 2018 May; 48(3):188-192. PubMed ID: 29054298
[TBL] [Abstract][Full Text] [Related]
20. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
